Pyxis Oncology Inc
PYXS
Get informed when a big investor buys or sells
+ FollowMarket Cap$114.04M
Close$
$0.39
76.9% downside
Current Fair Value
76.9% downsideOvervalued by 76.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $114.04 Million |
|---|---|
| Enterprise Value | $125.06 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.28 |
| Beta | 1.43 |
| Outstanding Shares | 63,469,850 |
Return
| Return on Equity | -261.40% |
|---|---|
| Return on Assets | -127.12% |
| Return on Invested Capital | -181.38% |
Valuation & Multiples
| P/E Ratio | -1.4 |
|---|---|
| PEG | -13.99 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 9.02 |
| Enterprise Value to EBIT | -1.44 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0.58 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$10.94 M
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.34
Average shareholder expectationRevenue Estimate
$21,875
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 23.10% |
|---|---|
| Total Calls | 134,900▼ 47.26% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 44.35%▼ 3.92% |
|---|---|
| Total Invested | $40.51M▲ 16.65% |
| Investors Holding | 80▼ 1.00% |
ESG Score
No data